This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
SpePharm Holdings BV (cancer and critical care therapeutics) raised €16mm ($23.6mm) through a private financing from TVM Capital, Signet Healthcare Partners, Paul Capital Healthcare, and members of the company's senior management team. SpePharm concurrently announced a €10mm revenue interest acquisition financing agreement signed with Paul Capital to fund the recent purchase of European rights to Dantrium for hyperthermia from Procter & Gamble.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?